Related Experiment Video
Updated: Mar 20, 2026

Rapid One-step Enzymatic Synthesis and All-aqueous Purification of Trehalose Analogues
Published on: February 17, 2017
Trehalose pathway as an antifungal target
John R Perfect1, Jennifer L Tenor1, Yi Miao1
1a Departments of Medicine and Biochemistry , Duke University Medical Center , Durham , NC , USA.
Abstract:
With an increasing immunocompromised population which is linked to invasive fungal infections, it is clear that our present 3 classes of antifungal agents may not be sufficient to provide optimal management to these fragile patients. Furthermore, with widespread use of antifungal agents, drug-resistant fungal infections are on the rise. Therefore, there is some urgency to develop the antifungal pipeline with the goal of new antifungal agent discovery. In this review, a simple metabolic pathway, which forms the disaccharide, trehalose, will be characterized and its potential as a focus for antifungal target(s) explained. It possesses several important features for development of antifungal agents. First, it appears to have fungicidal characteristics and second, it is broad spectrum with importance across both ascomycete and basidiomycete species. Finally, this pathway is not found in mammals so theoretically specific inhibitors of the trehalose pathway and its enzymes in fungi should be relatively non-toxic for mammals. The trehalose pathway and its critical enzymes are now in a position to have directed antifungal discovery initiated in order to find a new class of antifungal drugs.
Insights
New antifungal drug discovery is crucial due to rising infections and resistance. Targeting the fungal trehalose pathway offers a promising, broad-spectrum, and potentially non-toxic approach for developing novel antifungal agents.
Area of Science:
- Mycology
- Biochemistry
- Drug Discovery
Background:
- Increasing immunocompromised populations are susceptible to invasive fungal infections.
- Current antifungal agents face challenges from widespread use, leading to drug resistance.
- There is an urgent need for novel antifungal agents and a robust drug discovery pipeline.
Purpose of the Study:
- To characterize the trehalose metabolic pathway in fungi.
- To evaluate the trehalose pathway as a potential target for new antifungal agents.
- To explore the feasibility of developing specific inhibitors for fungal trehalose enzymes.
Main Methods:
- Review of existing literature on fungal trehalose metabolism.
- Analysis of the trehalose pathway's characteristics for antifungal development.
- Assessment of the pathway's presence and absence in mammalian systems.
Main Results:
- The trehalose pathway exhibits fungicidal characteristics.
- This pathway is broad-spectrum, effective across Ascomycete and Basidiomycete species.
- The pathway is absent in mammals, suggesting theoretical low toxicity for specific inhibitors.
Conclusions:
- The trehalose pathway presents a viable target for antifungal drug discovery.
- Targeting trehalose synthesis could lead to a new class of antifungal drugs.
- Developing specific inhibitors for fungal trehalose enzymes may offer a safe and effective treatment strategy.
Related Concept Videos
Antifungal Agents
Export of Misfolded Proteins out of the ER
Fungal Group Zygomycota
Lysosomal Hydrolases
Other Glycolytic Pathways

